TY  - GEN
DO  - 10.1093/grurint/ikad044
DO  - doi
ID  - 48632
JF  - GRUR International
KW  - Patents
KW  - Pharmaceuticals.
KW  - Patent medication.
KW  - Pharmaceutical policy.
KW  - Patents.
KW  - COVID-19 (Disease)
LA  - eng
LK  - https://doi.org/10.1093/grurint/ikad044
T1  - Criteria to Assess Whether a Medicine Should Be Entered in the List of Reimbursable Treatments.
TI  - Criteria to Assess Whether a Medicine Should Be Entered in the List of Reimbursable Treatments.
UR  - https://doi.org/10.1093/grurint/ikad044
VL  - 72, 5, 2023
ER  -